Abbott Lodges New Zemplar Patent Suit Against Hospira
Chicago-based Abbott, along with fellow plaintiff the Wisconsin Alumni Research Foundation, claims that Hospira infringed its patent when it lodged a New Drug Application with the U.S. Food and Drug Administration for approval to manufacture and sell paricalcitol injectable drug products before the expiration of Abbott's patent.
At issue is U.S. Patent...
Already a subscriber? Click here to login